A biotechnology company specializing in oncology was developing novel bispecific antibody therapeutics and engaged Worldwide Clinical Trials to support the advancement of its clinical programs. The selection of Worldwide as the contract research organization was driven by strategic factors, including its deep GI oncology expertise, strategic guidance, full-service support, and a reputation for agile, responsive project management, well-suited to the complexities of the sponsor’s first U.S. study.
Read our case study to learn more.
